Tag: pharmaceutical strategy

Stephen D. Hess, Ph.D.: Transforming Scientific Insight Into Global Therapeutic Impact

I am pleased to share a deeper look into my professional journey and the experiences that have shaped my career across global drug discovery, biotechnology, and scientific leadership. Over the past several decades, I’ve had the privilege of contributing to meaningful research, guiding innovative teams, and supporting the growth of emerging therapeutic programs around the world. Here is my biography.

Suresh Balachandran: A Legacy of Vision, Strategy, and Transformation in Healthcare and Technology

I'm excited to share a deeper look into my professional journey—spanning over 30 years of experience in healthcare, technology, and data strategy. Throughout my career, I've focused on building strong teams, driving innovation, and creating meaningful value for patients, providers, and partners. Here is my biography.

Beckinam Nowatzke, MSc, RAC: Architect of Quality, Regulatory Visionary, and Champion of Innovation in Life Sciences

Beckinam Nowatzke, MSc, RAC, is a global life sciences executive with 25+ years leading quality, regulatory, and continuous improvement across pharma, biotech, and medical devices. Known for scaling quality systems, authoring FDA submissions, and building cultures of innovation, she is now seeking board and advisory opportunities with organizations driving medical innovation, patient access, and regulatory excellence.

Susan Essumang: Global Clinical Operations Leader Driving Strategic, Patient-Focused Innovation in Pharma & Biotech

Susan Essumang is a seasoned clinical operations executive who merges scientific rigor with strategic leadership to drive high-impact pharmaceutical and biotech programs. Known for her patient-centric approach, Susan has led the development and regulatory success of globally recognized treatments, including Victoza®, Ozempic®, and Wegovy®, delivering billions in projected revenue. Her ability to align enterprise objectives with operational excellence has resulted in accelerated trial timelines, significant cost savings, and flawless regulatory inspections. With deep therapeutic expertise, a foundation in neuroscience and healthcare administration, and a commitment to innovation, Susan continues to shape the future of clinical research through data-driven insights and strategic execution.